Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study.

Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T; HERS Research Group..

Obstet Gynecol. 2001 Jan;97(1):116-20.

PMID:
11152919
2.

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.

Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E.

Am J Med. 2002 Nov;113(7):543-8.

PMID:
12459399
4.

Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group.

Fantl JA, Bump RC, Robinson D, McClish DK, Wyman JF.

Obstet Gynecol. 1996 Nov;88(5):745-9.

PMID:
8885906
5.

Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors.

Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B; Heart and Estrogen/Progestin Replacement Study Research Group..

Obstet Gynecol. 2001 Dec;98(6):1045-52.

PMID:
11755552
6.

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators..

J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76.

PMID:
16174858
7.

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.

Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR; Women's Health Initiative Investigators..

Obstet Gynecol. 2005 May;105(5 Pt 1):1063-73.

PMID:
15863546
8.

Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group.

Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF.

Obstet Gynecol. 1999 Jul;94(1):66-70.

PMID:
10389720
9.

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study..

Ann Intern Med. 2003 Jan 7;138(1):1-9.

PMID:
12513038
10.

Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen.

Goldstein SR, Johnson S, Watts NB, Ciaccia AV, Elmerick D, Muram D.

Menopause. 2005 Mar;12(2):160-4.

PMID:
15772563
11.

Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.

Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH.

Ann Intern Med. 2001 Oct 2;135(7):493-501.

PMID:
11578152
12.

Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.

Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.

Menopause. 2008 Nov-Dec;15(6):1060-4. doi: 10.1097/gme.0b013e31816d8171.

PMID:
18521047
13.

Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative.

Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL.

Am J Clin Nutr. 2005 Sep;82(3):651-6.

14.

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.

Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E.

Obstet Gynecol. 1998 Dec;92(6):982-8.

PMID:
9840563
15.

Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.

Reuben DB, Palla SL, Hu P, Reboussin BA, Crandall C, Herrington DM, Barrett-Connor E, Greendale GA.

Am J Med. 2006 Feb;119(2):167.e1-8.

PMID:
16443423
16.

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

Ann Intern Med. 2000 May 2;132(9):689-96.

PMID:
10787361
17.

The effects of hormones on urinary incontinence in postmenopausal women.

Quinn SD, Domoney C.

Climacteric. 2009 Apr;12(2):106-13. doi: 10.1080/13697130802630083. Review.

PMID:
19259853
18.

Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS).

Cauley JA, Black DM, Barrett-Connor E, Harris F, Shields K, Applegate W, Cummings SR.

Am J Med. 2001 Apr 15;110(6):442-50.

PMID:
11331055
19.

Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.

Khullar V, Hill S, Laval KU, Schi√łtz HA, Jonas U, Versi E.

Urology. 2004 Aug;64(2):269-74; discussion 274-5.

PMID:
15302476
20.

Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.

Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L Jr.

Obstet Gynecol. 2004 Feb;103(2):267-73.

PMID:
14754694

Supplemental Content

Support Center